P3 Health Partners Inc. (NASDAQ:PIII) Sees Significant Growth in Short Interest

P3 Health Partners Inc. (NASDAQ:PIII) was the target of a large increase in short interest in May. As of May 15th, there was short interest totaling 283,541 shares, an increase of 293.3% from the April 30th total of 72,094 shares. Currently, 4.8% of the company’s stock are sold short. Based on an average daily volume of 6,174,785 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Investors Weigh In On P3 Health Partners

A hedge fund recently bought a new stake in P3 Health Partners stock. Lido Advisors LLC acquired a new position in P3 Health Partners Inc. (NASDAQ:PIII) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,748 shares of the company’s stock, valued at approximately $33,000. Lido Advisors LLC owned 0.15% of P3 Health Partners as of its most recent SEC filing. 7.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PIII. TD Cowen reissued a “hold” rating and issued a $14.00 price objective (up from $3.00) on shares of P3 Health Partners in a report on Friday, May 22nd. Weiss Ratings raised P3 Health Partners from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday. Lake Street Capital reiterated a “buy” rating and issued a $14.00 target price (up from $4.00) on shares of P3 Health Partners in a research report on Friday, May 15th. Finally, UBS Group set a $14.00 price target on P3 Health Partners in a report on Friday, May 15th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $14.00.

P3 Health Partners Stock Down 26.0%

PIII opened at $12.18 on Friday. The company’s 50-day moving average price is $5.02 and its 200 day moving average price is $4.14. P3 Health Partners has a fifty-two week low of $1.52 and a fifty-two week high of $16.89. The firm has a market cap of $88.24 million, a price-to-earnings ratio of -0.32 and a beta of 0.48.

P3 Health Partners (NASDAQ:PIII) last posted its earnings results on Thursday, May 14th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of ($4.85) by $5.17. The company had revenue of $386.39 million during the quarter, compared to analyst estimates of $391.45 million. P3 Health Partners had a negative return on equity of 302.33% and a negative net margin of 8.57%.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.